Consortium of Aging, Dementia and Latino Studies

The main goal of the Consortium is to promote collaborations among investigators working on Alzheimer’s disease and related dementias in the US Latino/Hispanic population to accelerate research and the discovery of biomarkers, new diagnostics, prevention and treatment. The Consortium will focus on five key areas:

1) genomics and biomarkers

2) diagnosis and assessment

3) dementia risk and prevention

4) clinical trials and therapeutics, and

5) caregivers and psychosocial support interventions

This Consortium is unprecedented in that it includes investigators with diverse research interests and expertise in basic, clinical, translational and public health sciences from various regions throughout the U.S. The Consortium members have ongoing research studies that enroll individuals from ethnic and culturally diverse communities including older Latino adults of Mexican, Central and South American backgrounds, as well as of the Caribbean islands.  Members also have active working relationships with community-based organizations that result in powerful alliances to help the Consortium to carry out new research projects and recruit older Latino adults into their studies. Investigators participating in the Consortium may partner in the writing of new research grant applications, but consortium activities are not limited to a specific grant/project.

The objectives of the Consortium are to:

  • Provide a framework to foster US collaborations among investigators to advance Alzheimer’s disease and related dementias research in Latinos/Hispanics;
  • Provide a forum for the discussion, development and pursuit of new collaborative studies and research directions;
  • Support the development of early career researchers; and
  • Advance the knowledge of Alzheimer’s disease and related dementias in the US Latino/Hispanic population to improve our understanding of disease etiology, diagnosis, prevention and treatment in this population.

Special Interest Groups:

  1. Data infrastructure/harmonization
  2. Blood biomarkers
  3. Cognitive assessment
  4. Modifiable risk factors
  5. Recruitment and clinical trials
  6. Caregivers interventions
  7. Early career investigators

Consortium Inaugural Members

InvestigatorAffiliation
Yakeel T. Quiroz, PhDHarvard Medical School, Massachusetts General Hospital
Melissa Lamar, PhDRush Alzheimer’s Disease Center, Rush University Medical Center Institute for Minority Health Research, Department of Medicine, University of Illinois at Chicago
Hector M. González, PhDUC San Diego, Neurosciences, Shiley-Marcos ADRC
Adam M. Brickman, PhDTaub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology
Columbia ADRC
Miriam J Rodriguez, PhDAlbizu University
1FL ADRC
Clara Vila-Castelar, PhDHarvard Medical School, Massachusetts General Hospital
Katya Rascovsky, PhDUniversity of Pennsylvania
Alzheimer’s Disease Research Center and Department of Neurology
Sid O’Bryant, PhDUniversity of North Texas Health Science Center
Institute for Translational Research
David X. Marquez, PhDDepartment of Kinesiology and Nutrition, University of Illinois at Chicago
Rush Alzheimer’s Disease Center, Rush University Medical Center

Follow us on Twitter: